Lymphoproliferative disease in a cotton-top marmoset after inoculation with infectious mononucleosis-derived Epstein-Barr virus
- PMID: 168158
- DOI: 10.1002/ijc.2910150617
Lymphoproliferative disease in a cotton-top marmoset after inoculation with infectious mononucleosis-derived Epstein-Barr virus
Abstract
Injection of concentrated EBV derived from cells of the Kaplan line of infectious mononucleosis (IM) origin resulted in malignant lymphoproliferation in one out of three cotton-top marmosets 6 weeks after inoculation. Two additional animals receiving the same isolate after incubation with an antibody-containing human serum did not develop tumors. Inoculation of concentrated virus derived from the P3HR-1 line of Burkitt origin did not lead to lymphoproliferations in five marmosets. Three of these received non-neutralized, and two received neutralized P3HR-1 virus. The tumor obtained with the Kaplan isolate revealed characteristics of a lymphosarcome. It contained EBV-specific DNA. In addition, EBV-synthesizing lymphoblastoid lines were established from a tumorous lymph-node, as well as from the spleen of the diseased marmoset. Virus recovered from these lines transformed lymphocytes derived from spleens of healthy marmosets. The tumor-bearing animal developed low levels of anti-VCA antibodies during the course of tumor growth. These data demonstrate the oncogenic potential of EBV directly derived from cells of IM origin.
Similar articles
-
Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses.J Exp Med. 1977 Apr 1;145(4):948-67. doi: 10.1084/jem.145.4.948. J Exp Med. 1977. PMID: 192829 Free PMC article.
-
Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.J Virol. 1976 Jun;18(3):1071-80. doi: 10.1128/JVI.18.3.1071-1080.1976. J Virol. 1976. PMID: 178913 Free PMC article.
-
Response of marmosets to experimental infection with Epstein-Barr virus.IARC Sci Publ (1971). 1975;(11 Pt 2):161-8. IARC Sci Publ (1971). 1975. PMID: 191357
-
Epstein-Barr virus and nonhuman primates: natural and experimental infection.Adv Cancer Res. 1976;23:171-201. doi: 10.1016/s0065-230x(08)60546-1. Adv Cancer Res. 1976. PMID: 179290 Review. No abstract available.
-
Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.Rev Infect Dis. 1982 Sep-Oct;4(5):1048-61. doi: 10.1093/clinids/4.5.1048. Rev Infect Dis. 1982. PMID: 6293034 Review.
Cited by
-
Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses.J Exp Med. 1977 Apr 1;145(4):948-67. doi: 10.1084/jem.145.4.948. J Exp Med. 1977. PMID: 192829 Free PMC article.
-
Urgency and necessity of Epstein-Barr virus prophylactic vaccines.NPJ Vaccines. 2022 Dec 9;7(1):159. doi: 10.1038/s41541-022-00587-6. NPJ Vaccines. 2022. PMID: 36494369 Free PMC article. Review.
-
The antiviral prophylaxis of post-transplant lymphoproliferative disorder.Springer Semin Immunopathol. 1998;20(3-4):437-53. doi: 10.1007/BF00838054. Springer Semin Immunopathol. 1998. PMID: 9870256 Review. No abstract available.
-
Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection.PLoS Pathog. 2009 Oct;5(10):e1000606. doi: 10.1371/journal.ppat.1000606. Epub 2009 Oct 2. PLoS Pathog. 2009. PMID: 19798430 Free PMC article.